News & Articles
Selected Filters:
Quanterix granted Breakthrough Device designation from U.S. FDA for NfL test for multiple sclerosis
Blood-based assay has the potential to serve the multiple sclerosis (MS) community in management of relapsing-remitting form of the disease
CBD production: Ensuring safety, legality, and quality in the beauty industry
Tariq Hasan reveals how the CBD beauty trend evolved, emerging analytical challenges, and where the industry is headed
Better food, better health, better world: Delivering safer food and productivity with the help of mass spectrometry
Food testing expert, Marco Redaelli, shares his mission to make the world a healthier place, and reveals the technologies helping to deliver more reliable and faster results than ever before
Find the latest news from the 32nd European Congress of Clinical Microbiology & Infectious Diseases on SelectScience
SelectScience editors will be covering ECCMID 2022 so you can be sure not to miss out on top technology stories, product launches and latest research news from the event
Evaluating oncology drugs in patient tumors with preserved native tumor microenvironment
Watch this on-demand webinar to gain insight into a novel platform designed to rapidly evaluate preclinical drug candidates
Scitara announces collaboration with PerkinElmer Informatics to create a new model of the modern lab
The combination of technologies facilitates a fully connected laboratory with standard data integrity, data mobility, system flexibility, and user reconfigurability
Bio-Rad enhances multiplex flow cytometry with three new StarBright UltraViolet dyes
The StarBright UltraViolet 510, StarBright UltraViolet 665, and StarBright UltraViolet 795 Dyes offer enhanced brightness with narrow excitation and emission profiles to support multiplex panels
PathogenDx receives industry-first AOAC certification to detect bacterial and fungal species in a single well test for cannabis matrices
Molecular-based testing technology has shortest processing time of any multiplex microbial assay accepted by a regulatory agency
New GMP-manufactured Cas9 protein enables clinical genome editing research
Gibco CTS TrueCut Cas9 Protein supports use of genome editing for research and manufacturing applications, including CAR T-cell therapy research
Beckman Coulter Life Sciences launches new CellMek SPS, a fully automated sample preparation system for clinical flow cytometry
The innovative instrument helps clinical flow cytometry labs automate end-to-end sample preparation
4 upcoming webinars to help reach your research goals
Discover the latest tools and techniques to expand your research capacity with expert-led presentations on chromatography, drug discovery, biosafety, and more
Specialist assay kits and microplates for cancer research
Porvair’s growing range of Chromatrap® ChIP kits for epigenetics research show promise
UCLA-led team creates first comprehensive map of human blood stem cell development
UCLA scientists’ confirmation of this process clarifies a longstanding controversy about blood stem cells’ cellular origin
Sample Management Innovation at Analytica 2022
Ziath to launch two new innovative sample management products at Analytica 2022
Cherry-picking and reformatting tubes from Acoustix racks
New adaptor kit simplifies and improves the speed of Acoustix tube picking
Accelerating tube picking & selection
The Mohawk tube selector and picker from Ziath is designed to provide an intuitive interface for fast and effortless operation without the need for a fully-robotic system
Agilent highlights genomics and cell analysis solutions for cancer research at AACR 2022
Agilent Technologies showcased its cancer research innovations in cell analysis and genomics at the American Association for Cancer Research Annual Meeting
Novel COVID-19 vaccine may provide protection for cancer patients with B-cell deficiencies
The peptide-based vaccine induces a T cell-dependent response
Leukemia patients with certain gene regulation patterns may be less likely to respond to CAR T therapy
The epigenomic signature is evident prior to CD19-targeted CAR T-cell treatment
Some Latino children diagnosed with acute lymphoblastic leukemia face higher risk of relapse compared to non-Latino children
Latinos are also more likely to be diagnosed with this cancer type
DNA Script launches early access program for latest advancements to the SYNTAX Platform and Enzymatic DNA Synthesis Technology
Program participants will receive early access to the upcoming release of kits designed to print longer oligos and enable labeling with fluorophores, quenchers, and biotin